Ke‐Wei Zhu
- Topics
- Acute Myeloid Leukemia Research (7 papers)COVID-19 Clinical Research Studies (3 papers)Histone Deacetylase Inhibitors Research (3 papers)
- Journals
- Scientific ReportsBiochemical and Biophysical Research CommunicationsJournal of Materials Chemistry A
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Ke‐Wei Zhu
29 papers receiving 512 citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 268
- Cancer Research 156
- Oncology 75
- Pulmonary and Respiratory Medicine 66
- Hematology 65
Countries citing papers authored by Ke‐Wei Zhu
This map shows the geographic impact of Ke‐Wei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Wei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Wei Zhu more than expected).
Fields of papers citing papers by Ke‐Wei Zhu
This network shows the impact of papers produced by Ke‐Wei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Wei Zhu. The network helps show where Ke‐Wei Zhu may publish in the future.
Co-authorship network of co-authors of Ke‐Wei Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Ke‐Wei Zhu. A scholar is included among the top collaborators of Ke‐Wei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke‐Wei Zhu. Ke‐Wei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 29 | |
| 7 | 6 | |
| 8 | 4 | |
| 9 | 6 | |
| 10 | 6 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 3 | |
| 14 | 42 | |
| 15 | 2 | |
| 16 | 11 | |
| 17 | 24 | |
| 18 | 35 | |
| 19 | 72 | |
| 20 | 53 |
About Ke‐Wei Zhu
Ke‐Wei Zhu is a scholar working on Hematology, Internal Medicine and Cancer Research, having authored 31 papers that have together received 516 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), COVID-19 Clinical Research Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (156 citations), Hematology (65 citations) and Applied Microbiology and Biotechnology (9 citations). Ke‐Wei Zhu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Wanchun Wang, Yejia Zhang, Chen Ding, Xiaoping Chen, Shan Cao, Yan Han, Xiaoqing Yuan, Chen Ding, Hui Zeng and Jie Wen. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Materials Chemistry A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.